scholarly article | Q13442814 |
P356 | DOI | 10.1017/S0033291705006756 |
P698 | PubMed publication ID | 16388703 |
P50 | author | Matcheri S Keshavan | Q48067656 |
P2093 | author name string | John A Sweeney | |
James L Reilly | |||
Margret S H Harris | |||
P433 | issue | 4 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | schizophrenia | Q41112 |
P304 | page(s) | 485-494 | |
P577 | publication date | 2006-01-03 | |
P1433 | published in | Psychological Medicine | Q7256364 |
P1476 | title | Longitudinal studies of antisaccades in antipsychotic-naive first-episode schizophrenia | |
P478 | volume | 36 |
Q47787028 | Accounting for group differences in study retention in a randomized trial of specialized treatment for first episode psychosis |
Q91806336 | Alterations in intrinsic fronto-thalamo-parietal connectivity are associated with cognitive control deficits in psychotic disorders |
Q26991569 | An Overview of the Association between Schizotypy and Dopamine |
Q34619903 | Behavioral response inhibition in psychotic disorders: diagnostic specificity, familiality and relation to generalized cognitive deficit |
Q35182103 | Cognitive control of gaze in bipolar disorder and schizophrenia. |
Q36426332 | Consider the context: blocked versus interleaved presentation of antisaccade trials |
Q36926053 | Disorders of saccades. |
Q33888153 | Effect of second-generation antipsychotics on cognition: current issues and future challenges |
Q46201976 | Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia |
Q35202584 | Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study |
Q34656464 | Effects of risperidone on procedural learning in antipsychotic-naive first-episode schizophrenia |
Q57978272 | Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy |
Q35215692 | Effects of second-generation antipsychotic medication on smooth pursuit performance in antipsychotic-naive schizophrenia |
Q34048579 | Elevated antisaccade error rate as an intermediate phenotype for psychosis across diagnostic categories |
Q37945156 | Evaluation of state and trait biomarkers in healthy volunteers for the development of novel drug treatments in schizophrenia. |
Q34127765 | Evidence from cluster analysis for differentiation of antisaccade performance groups based on speed/accuracy trade-offs |
Q30828715 | Failure to mobilize cognitive control for challenging tasks correlates with symptom severity in schizophrenia |
Q37699383 | Generalized and specific neurocognitive deficits in psychotic disorders: utility for evaluating pharmacological treatment effects and as intermediate phenotypes for gene discovery |
Q30442031 | Genetics, cognition, and neurobiology of schizotypal personality: a review of the overlap with schizophrenia |
Q50737831 | Neural correlates of impaired volitional action control in schizophrenia patients. |
Q35133191 | Neurobehavioral Abnormalities in First-Degree Relatives of Individuals With Autism |
Q37203360 | Neurobiology of the early course of schizophrenia |
Q30488649 | Neurocognitive allied phenotypes for schizophrenia and bipolar disorder |
Q37076346 | Oculomotor and neuropsychological effects of antipsychotic treatment for schizophrenia |
Q34235346 | Oculomotor and pupillometric indices of pro- and antisaccade performance in youth-onset psychosis and attention deficit/hyperactivity disorder |
Q35173870 | Pharmacological treatment effects on eye movement control |
Q42110133 | Psychiatry, neurology, and the role of the cerebellum |
Q36630970 | Reduced attentional engagement contributes to deficits in prefrontal inhibitory control in schizophrenia |
Q33803943 | Reduced functional connectivity in a right-hemisphere network for volitional ocular motor control in schizophrenia |
Q34425198 | Response inhibition and response monitoring in a saccadic countermanding task in schizophrenia |
Q35404577 | Response inhibition and response monitoring in a saccadic double-step task in schizophrenia |
Q37472068 | Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression |
Q38923332 | Schizophrenia and Infections: The Eyes Have It. |
Q46395890 | Sleep deprivation as an experimental model system for psychosis: Effects on smooth pursuit, prosaccades, and antisaccades |
Q38646709 | The Stochastic Early Reaction, Inhibition, and late Action (SERIA) model for antisaccades. |
Q36522001 | The antisaccade task as a research tool in psychopathology: a critical review |
Q30437913 | The effects of ketamine and risperidone on eye movement control in healthy volunteers |
Q44813180 | The effects of unilateral versus bilateral subthalamic nucleus deep brain stimulation on prosaccades and antisaccades in Parkinson's disease |
Q38860355 | The neural underpinnings of cognitive flexibility and their disruption in psychotic illness |
Q24644046 | The role of the cerebellum in schizophrenia: an update of clinical, cognitive, and functional evidences |
Q37308096 | The tell-tale tasks: a review of saccadic research in psychiatric patient populations |
Q34077386 | Top-down control of visual sensory processing during an ocular motor response inhibition task |
Q30450648 | Turning it upside down: areas of preserved cognitive function in schizophrenia |
Q43762923 | Volume increases in putamen associated with positive symptom reduction in previously drug-naive schizophrenia after 6 weeks antipsychotic treatment. |
Q31112471 | fMRI studies of eye movement control: investigating the interaction of cognitive and sensorimotor brain systems |